PaxMedica, Inc. financial data

Symbol
PXMD on OTC
Location
303 South Broadway, Suite 125, Tarrytown, NY
State of incorporation
Delaware
Fiscal year end
December 31
Latest financial report
10-Q - Q1 2024 - May 13, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 195 % +140%
Debt-to-equity 169 %
Return On Equity -1.15K % -140%
Return On Assets -428 % +29.5%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 7.41M shares -45.4%
Common Stock, Shares, Outstanding 7.47M shares -46.4%
Entity Public Float 4.1M USD
Weighted Average Number of Shares Outstanding, Basic 7.42M shares +898%
Weighted Average Number of Shares Outstanding, Diluted 7.42M shares +898%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax 0 USD
Research and Development Expense 4.09M USD +335%
General and Administrative Expense 11.7M USD +0.14%
Operating Income (Loss) -15.8M USD -25%
Nonoperating Income (Expense) -2.14M USD +48.9%
Net Income (Loss) Attributable to Parent -18.1M USD +11.5%
Earnings Per Share, Basic -6.34 USD/shares +81.4%
Earnings Per Share, Diluted -6.34 USD/shares +81.3%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 3.99M USD
Accounts Receivable, after Allowance for Credit Loss, Current 500K USD
Assets, Current 2.89M USD -39.1%
Assets 2.89M USD -39.1%
Accounts Payable, Current 480K USD
Employee-related Liabilities, Current 873K USD +71.1%
Accrued Liabilities, Current 965K USD -5.3%
Liabilities, Current 1.2M USD -33.1%
Liabilities 1.7M USD -23.3%
Retained Earnings (Accumulated Deficit) -55.7M USD -48.3%
Stockholders' Equity Attributable to Parent 1.19M USD -53%
Liabilities and Equity 2.89M USD -39.1%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -3.07M USD -2.85%
Net Cash Provided by (Used in) Financing Activities -15.3K USD -100%
Common Stock, Shares Authorized 200M shares 0%
Common Stock, Shares, Issued 7.47M shares -46.4%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 1.63M USD -59.2%
Deferred Tax Assets, Valuation Allowance 7.21M USD +49.2%
Deferred Tax Assets, Gross 7.21M USD +49.2%
Deferred Tax Assets, Operating Loss Carryforwards 5.41M USD +46.8%
Preferred Stock, Shares Authorized 10M shares 0%
Additional Paid in Capital 56.9M USD +41.9%
Deferred Tax Assets, Net of Valuation Allowance 0 USD
Share-based Payment Arrangement, Expense 1.51M USD -30.3%
Interest Expense 9.17K USD
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%